MED22
Basic information
Region (hg38): 9:133338312-133348131
Previous symbols: [ "SURF5" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MED22 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 15 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 2 | 0 |
Variants in MED22
This is a list of pathogenic ClinVar variants found in the MED22 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-133341510-C-T | not specified | Likely benign (Dec 05, 2024) | ||
9-133341516-C-T | not specified | Uncertain significance (Dec 25, 2024) | ||
9-133341534-C-T | not specified | Uncertain significance (Oct 12, 2021) | ||
9-133341548-G-A | not specified | Uncertain significance (Jan 21, 2025) | ||
9-133341587-G-A | not specified | Uncertain significance (Jan 20, 2025) | ||
9-133341609-A-C | not specified | Uncertain significance (Jan 21, 2025) | ||
9-133341618-C-G | not specified | Uncertain significance (Mar 05, 2024) | ||
9-133341620-G-A | not specified | Uncertain significance (Jun 29, 2022) | ||
9-133341657-C-T | not specified | Uncertain significance (Apr 25, 2022) | ||
9-133341658-G-A | Likely benign (May 01, 2022) | |||
9-133341666-G-A | not specified | Uncertain significance (Aug 28, 2024) | ||
9-133344164-A-G | not specified | Uncertain significance (Aug 07, 2024) | ||
9-133344201-C-T | not specified | Uncertain significance (Sep 17, 2021) | ||
9-133344222-G-A | not specified | Uncertain significance (Dec 05, 2022) | ||
9-133344324-C-T | not specified | Uncertain significance (Aug 19, 2024) | ||
9-133345174-T-C | not specified | Uncertain significance (Dec 08, 2023) | ||
9-133345243-C-G | not specified | Uncertain significance (Jan 22, 2024) | ||
9-133346578-T-C | not specified | Uncertain significance (Jun 16, 2024) | ||
9-133346586-A-G | not specified | Uncertain significance (Feb 27, 2024) | ||
9-133346655-T-A | not specified | Uncertain significance (Sep 27, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MED22 | protein_coding | protein_coding | ENST00000491289 | 4 | 9827 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000804 | 0.779 | 125719 | 0 | 29 | 125748 | 0.000115 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.370 | 112 | 124 | 0.906 | 0.00000817 | 1286 |
Missense in Polyphen | 31 | 37.85 | 0.81902 | 417 | ||
Synonymous | -0.277 | 64 | 61.2 | 1.05 | 0.00000482 | 407 |
Loss of Function | 1.13 | 8 | 12.3 | 0.651 | 8.82e-7 | 96 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000181 | 0.000181 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000112 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000161 | 0.000158 |
Middle Eastern | 0.000112 | 0.000109 |
South Asian | 0.000131 | 0.000131 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors.;
- Pathway
- Developmental Biology;Transcriptional regulation of white adipocyte differentiation
(Consensus)
Recessive Scores
- pRec
- 0.111
Intolerance Scores
- loftool
- 0.349
- rvis_EVS
- -0.07
- rvis_percentile_EVS
- 48.35
Haploinsufficiency Scores
- pHI
- 0.192
- hipred
- Y
- hipred_score
- 0.813
- ghis
- 0.551
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.919
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Med22
- Phenotype
- hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); skeleton phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II
- Cellular component
- cytoplasm;mediator complex
- Molecular function
- transcription coregulator activity;protein binding